GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Inc (NAS:IXHL) » Definitions » Insider Ownership

Incannex Healthcare (Incannex Healthcare) Insider Ownership : 21.54 % (As of May. 29, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Incannex Healthcare Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Incannex Healthcare's insider ownership is 21.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Incannex Healthcare's Institutional Ownership is 3.57%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Incannex Healthcare's Float Percentage Of Total Shares Outstanding is 99.31%.


Incannex Healthcare Insider Ownership Historical Data

The historical data trend for Incannex Healthcare's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Insider Ownership Chart

Incannex Healthcare Historical Data

The historical data trend for Incannex Healthcare can be seen below:

2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Insider Ownership 0.22 0.22 0.22 21.54 21.54

Incannex Healthcare Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Incannex Healthcare (Incannex Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Incannex Healthcare (Incannex Healthcare) Headlines

From GuruFocus